Using Gentamicin and Dexamethasone for Bronchiectasis Treatment
Official title: A Randomized Sham-Controlled Trial of Bronchoscopic Levofloxacin and Gentamicin Versus Sham in Mechanically Ventilated Bronchiectasis: Acute and 1-Year Outcomes
Run by Assiut University · NCT06209047 · Data updated 2026-11-12
This study tests whether using gentamicin and dexamethasone can help people with bronchiectasis who are on mechanical ventilation feel better and breathe easier during acute flare-ups.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 315 (estimated) |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Status | Recruiting |
| Started | October 15, 2023 |
| Main results expected | May 15, 2026 |
| Study ends | February 1, 2027 |
| Registry record updated | July 17, 2025 |
| Trial ID | NCT06209047 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with confirmed bronchiectasis and acute exacerbations requiring hospitalization.
✕Probably not a fit
Patients with active pulmonary tuberculosis or allergic bronchopulmonary aspergillosis may not benefit from this treatment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the safety and efficacy of local instillation of gentamicin and dexamethasone in patients with bronchiectasis experiencing acute exacerbations while on mechanical ventilation. The study aims to improve mucociliary clearance, reduce bacterial colonization, and alleviate airway inflammation through targeted treatment. Participants will undergo bronchoscopic airway clearance followed by the instillation of the medications to assess their impact on lung function and quality of life. The trial focuses on patients who require antibiotic treatment in a respiratory ICU setting.
Why it matters
Potential benefit: If successful, this approach could significantly reduce exacerbations and improve the quality of life for patients with bronchiectasis.
How similar studies have gone: While the specific combination of gentamicin and dexamethasone for bronchiectasis is novel, similar approaches targeting bacterial colonization and inflammation have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with bronchiectasis confirmed by high-resolution CT chest(HRCT) * patients with acute exacerbation of bronchiectasis who need antibiotic treatment at the hospital due to exacerbation * mechanically ventilated patients in the respiratory ICU * Age more than or equal to 18 years Exclusion Criteria: * patients with active pulmonary tuberculosis * patients with allergic bronchopulmonary aspergillosis * patients who underwent interventional bronchoscopy for hemoptysis * age less than 18 years
Where it's running
-
Assiut university hospitals
Asyut, Egypt Recruiting
Study contacts
- Principal investigator: Ali A Ali, MSc — Assiut University
- Study coordinator: Ali A Ali, MSc
- Email: aliabuzaid@aun.edu.eg
- Phone: +2001064756136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bronchoscopic Amikacin for Acute Exacerbations in Bronchiectasis
This study tests whether delivering amikacin directly into the lungs during bronchoscopy helps adults with acute bronchiectasis flare-ups.
-
Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups
This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.
-
Bronchiectasis Phenotype Identification Model for Adults
This study tests a baseline classifier to categorize adults with non-cystic fibrosis bronchiectasis into phenotype groups using data collected over time.
-
BASE: Aiming to test a simple, objective way to gauge bronchiectasis severity and predict flare-ups
This study tests a new BASE framework to classify how severe non-cystic fibrosis bronchiectasis is right now and see if it can predict 12 months of worsening or flare-ups.
-
Investigating how cold viruses affect bronchiectasis exacerbations
This study is trying to see if cold viruses make symptoms worse for people with bronchiectasis compared to healthy individuals.
-
Using acetylcysteine in bronchoalveolar lavage for bronchiectasis treatment
This study is testing if using acetylcysteine during a lung cleaning procedure can help people with bronchiectasis feel better and recover faster during flare-ups compared to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.